In particular, it is well known that obesity is characterized by insulin resistance and low-grade systemic inflammation, which may affect the oncological outcomes of NMIBC patients as a result of insulin, insulin-like growth factor 1(IGF-1), cytokines, and growth factor effects. Here, IGF1 is linked to obesity disorder.